Yes, I agree, Geo. I snapped up more shares today as well.

New Post Public Reply Private Reply Replies (1) Message Board
EliteYoda geo #2094

Yes, I agree, Geo. I snapped up more shares today as well. I never thought I would see it move back down to triple zero ranges but I thought while it got there today I may as well add more to my position, and add to my position I did! I think the current price is an outstanding entry point and actually I am a bit surprised that the stock has revisited these extremely low price ranges after so many fundamental positives have occurred with the company over recent weeks and months. I realize that there has been dilution in recent months amidst a lack of buying pressure which has caused a drop in the price but I happen to think the fall in price range is overdone to the downside.

At triple seven pps the market cap is a mere $800k. Does this make sense? Perhaps, but perhaps not. Even just concentrating on the potential profits from about 2,000 units of CannaCigs out there floating around, assuming a reasonable market premium of 5x the price/sales, and $50 profit per unit, we get very close to the current market cap, and yet the company has so much more potential than just this one factor to the valuation. It seems the market for now is only willing to pay 4x the total value or worth of the current inventory on hand of 2k units times $100 proceeds for each as a total valuation of the company, which in my opinion is a rather harsh way of valuing the company; its like they do not trust the company do get anything right, have any progress going forward and not having any potential for larger order or sales in the future. They seem to only want to value the company right now, as is, without any assumptions of any other revenue streams or worth going forward, whatsoever, as if they do not trust management to move forward on any of its plans, as if the entire story is dead here and now and will not move forward by one iota. To me this is a rather negative and pessimistic view of the potential for the company for the rest of this year and next. Perhaps instead the current share price does not actually properly price the company and does not reflect the true market valuation of the company. Perhaps the only meaning in the share price right now is merely the happenstance of the current buying pressure versus selling pressure or MM movements and without pressure from buyers there are always sellers at any level so the price continues to decline. I think its clear that right now more than any other time the RFMK stock is completely disjoint from the fundamental positive developments of the company and its business, which in my mind offers a significant investment opportunity.

GLTA!

$RFMK!

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 0

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 1

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 4

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
ing Brands Faces Legal Probe; Fiduciary Duties Questioned"> Continue Reading